Disc Medicine (IRON) EBITDA

annual EBITDA:

-$108.27M-$32.04M(-42.04%)
December 31, 2024

Summary

  • As of today (July 1, 2025), IRON annual EBITDA is -$108.27 million, with the most recent change of -$32.04 million (-42.04%) on December 31, 2024.
  • During the last 3 years, IRON annual EBITDA has fallen by -$77.37 million (-250.39%).
  • IRON annual EBITDA is now -250.39% below its all-time high of -$30.90 million, reached on December 31, 2021.

Performance

IRON EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIRONincome statement metrics

quarterly EBITDA:

-$33.05M-$19.80M(-149.41%)
March 1, 2025

Summary

  • As of today (July 1, 2025), IRON quarterly EBITDA is -$33.05 million, with the most recent change of -$19.80 million (-149.41%) on March 1, 2025.
  • Over the past year, IRON quarterly EBITDA has dropped by -$6.13 million (-22.78%).
  • IRON quarterly EBITDA is now -257.08% below its all-time high of $21.04 million, reached on December 1, 2021.

Performance

IRON quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIRONincome statement metrics

TTM EBITDA:

-$109.89M-$6.13M(-5.91%)
March 1, 2025

Summary

  • As of today (July 1, 2025), IRON TTM EBITDA is -$109.89 million, with the most recent change of -$6.13 million (-5.91%) on March 1, 2025.
  • Over the past year, IRON TTM EBITDA has dropped by -$31.84 million (-40.79%).
  • IRON TTM EBITDA is now -1054.76% below its all-time high of -$9.52 million, reached on March 1, 2020.

Performance

IRON TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIRONincome statement metrics

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

IRON EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-42.0%-22.8%-40.8%
3 y3 years-250.4%-232.4%-366.5%
5 y5 years-221.4%-247.3%-582.4%

IRON EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-250.4%at low-216.1%at low-868.2%at low
5 y5-year-250.4%at low-257.1%at low-868.2%at low
alltimeall time-250.4%at low-257.1%at low-1054.8%at low

IRON EBITDA History

DateAnnualQuarterlyTTM
Mar 2025
-
-$33.05M(+149.4%)
-$109.89M(+5.9%)
Dec 2024
-$108.27M(+42.0%)
-$13.25M(-59.7%)
-$103.76M(-1.6%)
Sep 2024
-
-$32.84M(+6.8%)
-$105.40M(+15.2%)
Jun 2024
-
-$30.74M(+14.2%)
-$91.49M(+17.2%)
Mar 2024
-
-$26.92M(+80.7%)
-$78.05M(+2.4%)
Dec 2023
-$76.23M(+60.9%)
-$14.89M(-21.3%)
-$76.23M(-0.1%)
Sep 2023
-
-$18.93M(+9.4%)
-$76.33M(+12.5%)
Jun 2023
-
-$17.30M(-31.1%)
-$67.85M(+8.5%)
Mar 2023
-
-$25.10M(+67.4%)
-$62.54M(+32.0%)
Dec 2022
-$47.39M
-$15.00M(+43.4%)
-$47.39M(+317.5%)
Sep 2022
-
-$10.46M(-12.8%)
-$11.35M(-41.1%)
DateAnnualQuarterlyTTM
Jun 2022
-
-$11.99M(+20.6%)
-$19.28M(-18.1%)
Mar 2022
-
-$9.94M(-147.3%)
-$23.55M(-23.4%)
Dec 2021
-$30.90M(-8.3%)
-
-
Dec 2021
-
$21.04M(-214.4%)
-$30.75M(-31.0%)
Sep 2021
-
-$18.39M(+13.1%)
-$44.56M(+30.9%)
Jun 2021
-
-$16.26M(-5.1%)
-$34.05M(+39.7%)
Mar 2021
-
-$17.14M(-337.1%)
-$24.37M(+45.5%)
Dec 2020
-$33.69M
$7.23M(-191.7%)
-$16.75M(-30.1%)
Sep 2020
-
-$7.88M(+19.6%)
-$23.98M(+48.9%)
Jun 2020
-
-$6.59M(-30.8%)
-$16.10M(+69.2%)
Mar 2020
-
-$9.52M
-$9.52M

FAQ

  • What is Disc Medicine annual EBITDA?
  • What is the all time high annual EBITDA for Disc Medicine?
  • What is Disc Medicine annual EBITDA year-on-year change?
  • What is Disc Medicine quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Disc Medicine?
  • What is Disc Medicine quarterly EBITDA year-on-year change?
  • What is Disc Medicine TTM EBITDA?
  • What is the all time high TTM EBITDA for Disc Medicine?
  • What is Disc Medicine TTM EBITDA year-on-year change?

What is Disc Medicine annual EBITDA?

The current annual EBITDA of IRON is -$108.27M

What is the all time high annual EBITDA for Disc Medicine?

Disc Medicine all-time high annual EBITDA is -$30.90M

What is Disc Medicine annual EBITDA year-on-year change?

Over the past year, IRON annual EBITDA has changed by -$32.04M (-42.04%)

What is Disc Medicine quarterly EBITDA?

The current quarterly EBITDA of IRON is -$33.05M

What is the all time high quarterly EBITDA for Disc Medicine?

Disc Medicine all-time high quarterly EBITDA is $21.04M

What is Disc Medicine quarterly EBITDA year-on-year change?

Over the past year, IRON quarterly EBITDA has changed by -$6.13M (-22.78%)

What is Disc Medicine TTM EBITDA?

The current TTM EBITDA of IRON is -$109.89M

What is the all time high TTM EBITDA for Disc Medicine?

Disc Medicine all-time high TTM EBITDA is -$9.52M

What is Disc Medicine TTM EBITDA year-on-year change?

Over the past year, IRON TTM EBITDA has changed by -$31.84M (-40.79%)
On this page